Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trials

Medical device clinical trials from ClinicalTrials.gov

Trial RECRUITING

Effect of Hyperoxygenated Environment on Maximal Muscle Strength

NCT NCT07558928

Start 2024-01-01

View Details →

Trial COMPLETED

Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation

NCT NCT06051539

Start 2023-10-10

View Details →

Trial RECRUITING

Transcranial Photobiomodulation (tPBM) for Somatic Symptoms in Treatment-Resistant Depression

NCT NCT07543328

Start 2026-01-06

View Details →

Trial RECRUITING

Validation of Donor Oocytes Semi-automated Vitrification

NCT NCT06238570

Start 2024-01-23

View Details →

Trial COMPLETED

Repetitive Peripheral Magnetic Stimulation Enhances Modified Constraint-Induced Movement Therapy Outcomes After Stroke

NCT NCT07559747

Start 2022-01-01

View Details →

Trial RECRUITING

Study on the Clinical Efficacy of Transcranial Strong Alternating Current (Hi-tACS) in Patients With Neuroimmune Diseases With Insomnia

NCT NCT07558616

Start 2025-09-01

View Details →

Trial RECRUITING

Multi-target TMS for Schizophrenia Negative Symptoms

NCT NCT07559084

Start 2026-05-01

View Details →

Trial RECRUITING

Foley Balloon for Cervical Preparation Before Dilation and Evacuation

NCT NCT06850974

Start 2025-02-10

View Details →

Trial RECRUITING

Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

NCT NCT05440760

Start 2022-08-08

View Details →

Trial NOT_YET_RECRUITING

FFR-Guided Revascularization in Atherosclerotic Renal Artery Stenosis

NCT NCT07511309

Start 2026-03-31

View Details →

Trial NOT_YET_RECRUITING

A Study of the Sleepnet Elara APAP Device

NCT NCT07559708

Start 2026-04-27

View Details →

Trial COMPLETED

EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

NCT NCT06390059

Start 2023-08-28

View Details →

Page 213 of 417

↑